CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+7.92%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$7.38B
AUM Growth
+$7.38B
(-8.4%)
Cap. Flow
-$1.04B
Cap. Flow
% of AUM
-14.16%
Top 10 Holdings %
Top 10 Hldgs %
59.41%
Holding
95
New
3
Increased
19
Reduced
47
Closed
2
Top Buys
| 1 |
Intercontinental Exchange
ICE
|
$302M |
| 2 |
Royalty Pharma
RPRX
|
$6.54M |
| 3 |
Sarepta Therapeutics
SRPT
|
$4.1M |
| 4 |
Vaxcyte
PCVX
|
$3.25M |
| 5 |
Neurocrine Biosciences
NBIX
|
$2.51M |
Top Sells
| 1 |
Fiserv
FI
|
$298M |
| 2 |
Visa
V
|
$117M |
| 3 |
Microsoft
MSFT
|
$108M |
| 4 |
Amazon
AMZN
|
$98.9M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$80M |
Sector Composition
| 1 | Financials | 30.22% |
| 2 | Technology | 14.76% |
| 3 | Healthcare | 12.87% |
| 4 | Industrials | 12.28% |
| 5 | Consumer Discretionary | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Elevance Health
ELV
$71.8B
| $35.4M | 0.48% | 91,054 +1,615 | +2% | +$628K |
|
27
Natera
NTRA
$23.1B
| $33.8M | 0.46% | 200,000 | – | – |
|
28
Edwards Lifesciences
EW
$47.8B
| $31M | 0.42% | 396,778 -1,540 | -0.4% | -$120K |
|
29
Insulet
PODD
$23.9B
| $29.8M | 0.4% | 94,908 -17,000 | -15% | -$5.34M |
|
30
Insmed
INSM
$28.8B
| $27.3M | 0.37% | 271,110 -50,000 | -16% | -$5.03M |
|
31
Tencent Music
TME
$37.8B
| $25.3M | 0.34% | 1,300,088 -181,518 | -12% | -$3.54M |
|
32
Mercado Libre
MELI
$125B
| $22.9M | 0.31% | 8,769 -74 | -0.8% | -$193K |
|
|
33
Royalty Pharma
RPRX
$15.6B
| $22.6M | 0.31% | 627,368 +181,530 | +41% | +$6.54M |
|
34
Medtronic
MDT
$119B
| $22.2M | 0.3% | 255,000 | – | – |
|
35
Service Corp International
SCI
$11.1B
| $21M | 0.29% | 258,413 +7,496 | +3% | +$610K |
|
36
Vertex Pharmaceuticals
VRTX
$100B
| $20.5M | 0.28% | 46,057 -8,000 | -15% | -$3.56M |
|
37
Penumbra
PEN
$10.6B
| $18.5M | 0.25% | 72,000 | – | – |
|
38
Zai Lab
ZLAB
$3.68B
| $17.8M | 0.24% | 510,000 +50,000 | +11% | +$1.75M |
|
39
Ionis Pharmaceuticals
IONS
$6.8B
| $17.8M | 0.24% | 450,000 +50,000 | +13% | +$1.98M |
|
40
Synopsys
SNPS
$112B
| $17.4M | 0.24% | 33,925 -378 | -1% | -$194K |
|
|
41
Neurocrine Biosciences
NBIX
$13.8B
| $17M | 0.23% | 135,000 +20,000 | +17% | +$2.51M |
|
42
Glaukos
GKOS
$5.5B
| $16.8M | 0.23% | 162,212 | – | – |
|
43
MakeMyTrip
MMYT
$9.4B
| $16M | 0.22% | 163,128 -37,836 | -19% | -$3.71M |
|
44
Align Technology
ALGN
$10.3B
| $15.8M | 0.21% | 83,428 | – | – |
|
45
KE Holdings
BEKE
$20.8B
| $14.9M | 0.2% | 840,816 -117,032 | -12% | -$2.08M |
|
46
PTC
PTC
$25.6B
| $14.7M | 0.2% | 85,487 -952 | -1% | -$164K |
|
47
ResMed
RMD
$40.2B
| $14.7M | 0.2% | 56,924 -632 | -1% | -$163K |
|
48
MSCI
MSCI
$43.9B
| $14.2M | 0.19% | 24,636 -272 | -1% | -$157K |
|
49
Tyler Technologies
TYL
$24.4B
| $14.1M | 0.19% | 23,718 -264 | -1% | -$157K |
|
50
Privia Health
PRVA
$2.83B
| $14M | 0.19% | 610,000 | – | – |
|